Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.
| Metric | VREX | SN | 4DX | ONCSM | MEDTR | ANGEN | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | — | 20.56● | — | 122.41 | 596.83 | — | 27.44 |
| P/B | 0.94 | 2.48 | -74.16● | 13.36 | 1.08 | 1.32 | 2.48 |
| EV/EBITDA | — | 9.88● | — | 25.46 | 10.93 | 34.77 | 15.23 |
| P/S | 0.52● | 2.09 | 243.16 | 7.66 | 1.18 | 2.95 | 2.66 |
| Metric | VREX | SN | 4DX | ONCSM | MEDTR | ANGEN | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.20 | 2.57 | 6.57● | 2.25 | 3.58 | 2.31 | 3.28 |
| Debt/Equity | 80.3% | 62.9% | -22.6%● | 35.0% | 1.0% | 28.1% | 44.7% |
| NetDebt/EBITDA | -47.21● | 1.72 | 0.71 | 0.42 | -1.64 | 4.71 | 0.82 |
| Metric | VREX | KIDS | VMD | OFIX | PACB | CLPT | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | — | — | 32.68 | — | — | — | 27.44 |
| P/B | 0.94 | 1.40 | 3.38 | 0.92● | 217.15 | 29.36 | 2.48 |
| EV/EBITDA | — | — | 9.23 | 5.46● | — | — | 15.23 |
| P/S | 0.52 | 1.94 | 1.70 | 0.49● | 3.21 | 13.62 | 2.66 |
| Metric | VREX | KIDS | VMD | OFIX | PACB | CLPT | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.20 | 5.21 | 1.22 | 2.87 | 5.65 | 5.79● | 3.28 |
| Debt/Equity | 80.3% | 31.4% | 8.6%● | 53.9% | 29,729.0% | 337.5% | 44.7% |
| NetDebt/EBITDA | -47.21● | -8.36 | 0.05 | 1.21 | -4.01 | -1.18 | 0.82 |
The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.